Welcome to Dwaey, specifically on Nebivolol page.
This medicine contains important and useful components, as it consists of
Nebivolol is available in the market in concentration.
Nebivolol
Before starting Nebivolol, it is essential to consult with a healthcare provider, especially if you have any of the following conditions:
- Heart Conditions: Nebivolol is a beta-blocker and should be used cautiously in patients with bradycardia (slow heart rate), heart failure, or heart block. Close monitoring is needed if you have a history of heart issues to avoid any potential exacerbation of symptoms.
- Asthma or Chronic Obstructive Pulmonary Disease (COPD): Nebivolol can potentially worsen symptoms of asthma or COPD since beta-blockers can constrict airways in some individuals. It is recommended to use it with caution in patients with these respiratory conditions.
- Liver or Kidney Impairment: If you have any liver or kidney problems, you should inform your doctor before starting Nebivolol, as these conditions may require dose adjustments or close monitoring.
- Diabetes: Beta-blockers can mask the symptoms of hypoglycemia (low blood sugar), such as tachycardia (increased heart rate). If you have diabetes, especially if you are prone to low blood sugar, your healthcare provider may monitor your blood sugar levels more frequently.
- Thyroid Disorders: Nebivolol can potentially mask the symptoms of an overactive thyroid (hyperthyroidism), such as tachycardia, so it should be used with caution in patients with thyroid disorders.
- Pregnancy and Lactation: Nebivolol is generally considered Category C during pregnancy, meaning its safety has not been well established. It should only be used if the benefits outweigh the risks. It is also not recommended during breastfeeding due to the potential for the drug to pass into breast milk.
Nebivolol is primarily prescribed for the following conditions:
- Hypertension (High Blood Pressure): Nebivolol is used to help manage high blood pressure. It works by relaxing the blood vessels and slowing down the heart rate, which reduces the workload on the heart and helps lower blood pressure.
- Heart Failure: Nebivolol is also used in the management of chronic heart failure in some patients. It helps improve heart function by lowering heart rate and reducing blood pressure, thus improving the heart's efficiency and reducing symptoms such as fatigue and shortness of breath.
Nebivolol should not be used in the following cases:
- Severe Bradycardia: Patients with a resting heart rate of less than 60 beats per minute should avoid using Nebivolol unless prescribed by a healthcare provider and closely monitored.
- Severe Liver Disease: Nebivolol is contraindicated in patients with severe liver impairment. The liver metabolizes this drug, and liver dysfunction can lead to elevated drug levels, increasing the risk of side effects.
- Severe Hypotension: If a patient has severe low blood pressure (hypotension), the use of Nebivolol is not recommended as it may exacerbate the condition.
- Cardiogenic Shock: In patients who are experiencing cardiogenic shock, Nebivolol should be avoided, as it may worsen heart function and circulation.
- Allergic Reactions: Known hypersensitivity or allergic reaction to Nebivolol or any of its ingredients should preclude its use.
Nebivolol may cause side effects, some of which are common and others more severe:
- Common Side Effects:
- Fatigue or feeling unusually tired.
- Headache or dizziness, especially when standing up quickly.
- Nausea, diarrhea, or other gastrointestinal discomfort.
- Cold hands and feet, which may occur due to reduced circulation.
- Serious Side Effects:
- Bradycardia (slow heart rate) or heart block: These can lead to dizziness, lightheadedness, or fainting. This is particularly concerning in patients with pre-existing heart conditions.
- Hypotension (low blood pressure), which may cause dizziness, fainting, or a general feeling of weakness.
- Worsening of Heart Failure: In some cases, beta-blockers may cause worsening symptoms in individuals with heart failure, particularly if the dose is too high.
- Respiratory Issues: Shortness of breath or wheezing can occur, especially in patients with asthma or COPD.
- Depression or mood changes: Some individuals may experience mood alterations, including feelings of depression, though this is less common.
- Allergic reactions, including swelling of the face, lips, or throat, which may require emergency medical attention.
3
Nebivolol is a beta-1 selective adrenergic antagonist (beta-blocker) that works by blocking the beta-1 adrenergic receptors in the heart. This action results in the following effects:
- Reduction in heart rate: By blocking beta-1 receptors, Nebivolol slows the heart rate and reduces the force of heart contractions, making the heart work less hard.
- Vasodilation: Nebivolol also has a unique property of promoting vasodilation (widening of blood vessels) by increasing the release of nitric oxide from the endothelium (lining of the blood vessels). This reduces blood pressure and helps to improve blood flow.
- These combined actions of slowing the heart rate and dilating blood vessels contribute to lowering blood pressure and improving symptoms of heart failure.
Nebivolol can interact with several other medications, which may affect its safety and effectiveness:
- Other Beta-blockers or Calcium Channel Blockers: Concomitant use of other beta-blockers (like atenolol or metoprolol) or calcium channel blockers (like verapamil or diltiazem) may significantly lower heart rate and blood pressure, increasing the risk of heart block or other serious cardiac effects.
- Antihypertensive Drugs: Nebivolol, when taken with other antihypertensive agents such as ACE inhibitors, angiotensin II receptor blockers (ARBs), or diuretics, can further lower blood pressure. This requires careful monitoring to avoid hypotension.
- Insulin and Oral Hypoglycemic Drugs: Beta-blockers like Nebivolol can mask symptoms of hypoglycemia. Thus, patients taking insulin or other drugs to lower blood sugar may need to adjust their medications or monitor blood glucose levels more frequently.
- Clonidine: Concurrent use of clonidine with Nebivolol should be avoided unless the clonidine is gradually discontinued after Nebivolol therapy is started. Abrupt withdrawal of clonidine may cause a rapid increase in blood pressure.
- Antiarrhythmic Medications: Combining Nebivolol with antiarrhythmic drugs (such as amiodarone or quinidine) may increase the risk of bradycardia or heart block, so these combinations should be used with caution.
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Long-term use of NSAIDs may reduce the effectiveness of Nebivolol in controlling blood pressure.
The typical adult dosing schedule for Nebivolol is as follows:
- Hypertension: The starting dose is usually 5 mg once daily. The dose can be increased to a maximum of 10 mg once daily based on the patient's response and tolerability.
- Heart Failure: For heart failure, the starting dose is typically 1.25 mg once daily, which can be gradually increased to a maximum of 10 mg daily depending on tolerance.
- Nebivolol is usually taken once a day, with or without food. Patients should take it consistently at the same time each day.
Nebivolol is not approved for use in pediatric patients. Its safety and efficacy in children and adolescents have not been established, and therefore, it should not be prescribed to individuals under 18 years of age.
It is crucial to consult with a healthcare provider before beginning treatment with Nebivolol to ensure it is the right medication for your health condition and to receive guidance on proper dosage, possible interactions, and monitoring requirements.
For patients with renal impairment, Nebivolol can generally be used with caution, but the dose may need to be adjusted:
- Mild to moderate renal impairment (eGFR 30-89 mL/min/1.73 m²): No dose adjustment is necessary for these patients, but careful monitoring is recommended.
- Severe renal impairment (eGFR <30 mL/min/1.73 m²): Nebivolol should be used with caution, and dose reduction may be necessary. Close monitoring for side effects such as hypotension or bradycardia is advised.
- End-stage renal disease (on dialysis): The use of Nebivolol in patients on dialysis is not well-studied, and caution should be exercised.
Not available in a medicine form yet